Protection against herpes B virus infection in rabbits with a recombinant vaccinia virus expressing glycoprotein D

Journal of Medical Virology

Volumn 57, Issue 1, 1999, Pages 47-56

  Bennett, A M ^a   Slomka, M J ^b,e   Brown, D W G ^b   Lloyd, G ^c   Mackett, M ^d  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d CHRISTIE HOSPITAL   (United Kingdom)

^e Murex Biotech Ltd   (United Kingdom)

Author keywords

Cercopithecine herpesvirus 1; Protective immune response; Recombinant vaccine

Indexed keywords

IMMUNOGLOBULIN D; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES VIRUS; HERPES VIRUS INFECTION; IMMUNITY; IMMUNOBLOTTING; NONHUMAN; RABBIT; VACCINATION; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BLOTTING, WESTERN; CERCOPITHECUS AETHIOPS; CLONING, MOLECULAR; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, CERCOPITHECINE; HUMANS; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; RABBITS; RECOMBINANT PROTEINS; VACCINES, SYNTHETIC; VACCINIA VIRUS; VERO CELLS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS; VIRAL VACCINES;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; DNA VIRUSES; HERPES; HERPESVIRIDAE; HERPESVIRUS 1; ORYCTOLAGUS CUNICULUS; VACCINIA; VACCINIA VIRUS;

EID: 0032889966     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199901)57:1<47::AID-JMV7>3.0.CO;2-V     Document Type: Article

References (57)

1. Advisory Committee on Dangerous Pathogens. 1995. Categorisation of biological agents according to hazard and categories of containment. 4th Edition. London: HMSO.
2. Bennett AM, Harrington L, Kelly DC. 1992. Nucleotide sequence analysis of genes encoding glycoproteins D and J in simian herpes B virus. J Gen Virol 73:2963-2967.
3. Blacklaws BA, Krishna S, Minson AC, Nash AA. 1990. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 177:727-736.
4. Blacklaws BA, Nash AA. 1990. Immunological memory to herpes simplex virus type 1 glycoproteins B and D in mice. J Gen Virol 71: 863-871.
5. Boulter EA, Kalter SS, Heberling RL, Guajardo JE, Lester TL. 1982. A comparison of neutralisation tests for the detection of antibodies to Herpesvirus simiae (Monkey B virus). Lab Anim Scie 32:150-152.
6. Boulter EA, Zwartouw HT, Thornton B. 1981. Postexposure immunoprophylaxis against B virus (Herpesvirus simiae) infection. Br Med J 283:1495-1497.
7. Bourne N, Milligan GN, Schleiss MR, Bernstein DI, Stanberry LR. 1996. DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2. Vaccine 14:1230-1234.
8. Bourne N, Stanberry LR, Bernstein DI, Lew D. 1996a. DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 173:800-807.
9. B Virus Working Group. 1988. Guidelines for prevention of Herpesvirus simiae (B virus) infection in monkey handlers. J Med Primatol 17:77-83.
10. Cantin EM, Eberle R, Baldick JL, Moss B, Willey DE, Notkins AL, Openshaw H. 1987. Expression of herpes simplex virus (HSV-1) glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal HSV-1 infection. Proc Natl Acad Sci USA 84: 5908-5912.
11. Carroll M. 1993. Expression analysis and immunogenicity of human immunodeficiency virus type 1 envelope glycoprotein in vaccinia virus. Ph.D. thesis, Faculty of Medicine, University of Manchester.
12. Chabalgoity JA, Khan CMA, Nash AA, Hormaeche CE. 1996. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection. Mol Microbiol 19:791-801.
13. Chou Q, Russell M, Birch DE, Raymond J, Bloch W. 1992. Prevention of PCR mis-priming and primer dimerization improves low copy number amplifications. Nucleic Acids Res 20:1717-1723.
14. Corey L. 1997. Developing a genital herpes simplex virus vaccine. In: Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada. Washington: American Society for Microbiology.
15. Cremer KJ, Mackett M, Wohelenberg C, Notkins AL, Moss B. 1985. Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice. Science 228:737-740.
16. Cropper LM, Lees DN, Patt R, Sharp IR, Brown D. 1992. Monoclonal antibodies for the identification of herpesvirus simiae (B virus). Arch Virol 123:267-277.
17. DiGiacomo RF. 1988. Guidelines for prevention of Herpesvirus simiae (B virus) infection in monkey handlers (letter). Lab Anim Scie 38:558.
18. Eberle R, Black D, Hilliard JK. 1989. Relatedness of glycoproteins expressed on the surface of simian herpesvirus virions and infected cells to specific HSV glycoproteins. Arch Virol 109:233-252.
19. Eberle R, Black D, Lipper S, Hilliard JK. 1995. Herpesvirus papio 2, an SA8-like α-herpesvirus of baboons. Arch Virol 140:529-545.
20. Eberle R, Hilliard J. 1995. The simian herpesviruses. Infect Agents Dis 4:55-70.
21. Eberle R, Mou SW. 1983. Relative titers of antibodies to individual polypeptide antigens of herpes simplex virus type 1 in human sera. J Infect Dis 148:436-444.
22. Fierer J, Bazeley P, Brand AI. 1973. Herpes encephalomyelitis presenting as ophthalmic Zoster. Ann Intern Med 79:225-228.
23. Freifield AG, Hilliard J, Southers J, Murray M, Savarese B, Schmitt JM, Straus SE. 1995. A controlled seroprevalence survey of primate handlers for evidence of asymptomatic Herpes B virus infection. J Infect Dis 171:1031-1034.
24. Harlow E, Lane D. 1988. Antibodies - A laboratory manual. New York: Cold Spring Harbor Laboratory Press.
25. Harrington L, Wall LVM, Kelly DC. 1992. Molecular cloning and physical mapping of the genome of simian herpes B virus and comparison of genome organization with that of herpes simplex virus type 1. J Gen Virol 73:1217-1226.
26. Holmes GP, Chapman LE, Stewart JA, Straus SE, Hilliard JK, Davenport DS and the B Virus Working Group. 1995. Guidelines for the prevention and treatment of B-virus infections in exposed persons. Clin Infect Dis 20:421-439.
27. Holmes GP, Hilliard JK, Klontz KC, Rupert AH, Schindler CM, Parrish E, Griffin DG, Ward GS, Bernstein ND, Bean TW, Ball MR, Brady JA, Wilder MH, Kaplan JE. 1990. B virus (Herpesvirus simiae) infection in humans: Epidemiological investigation of a cluster. Ann Intern Med 112:833-839.
28. Hull RN, Nash JC. 1960. Immunisation against B virus infection, I. Preparation of an experimental vaccine. Am J Trop Med Hyg 71: 15-18.
29. Hull RN. 1971. B virus vaccine. Lab Anim Scie 21:1068-1071.
30. Hull RN, Peck FBJr, Ward TG, Nash JC. 1962. Immunisation against B virus infection, II. Further laboratory and clinical studies with an experimental vaccine. Am J Trop Med Hyg 76:239-251.
31. Isaacs SN, Kotwal GJ, Moss B. 1990. Reverse guanine phosphoribosyltransferase selection of recombinant vaccinia viruses. Virology 178:626-630.
32. Lees DN, Baskerville A, Cropper LM, Brown DWG. 1991. Herpesvirus simiae (B virus) antibody response and virus shedding in experimental primary infection of cynomolgus monkeys. Lab Anim Scie 41:360-364.
33. Mackett M, Smith GL, Moss B. 1984. General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol 49:857-864.
34. Mayr A, Hochstein-Mintzel V, Stickl H. 1975. Abstammung, Eigenschaften und Verwendung des attenuierten vaccinia-stammes MVA. Infection 3:6-14.
35. McCarthy K, Tosolini FA. 1975. A review of primate herpes viruses. Proc R Soc Med 68:145-150.
36. McClements WL, Armstrong ME, Keys RD, Liu MA. 1996. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA 93:11414-11420.
37. McKenzie R, Straus SE. 1996. Vaccine therapy for herpes simplex virus infections: An historical perspective. Rev Med Virol 6:85-96.
38. Morgan AJ, Mackett M, Finerty S, Arrand JR, Scullion FT and Epstein MA. 1988. Recombinant vaccinia virus expressing Epstein-Barr virus glycoprotein gp340 protects cotton top tamarins against EB virus-induced malignant lymphomas. J Med Virol 25:185-195.
39. Petrovskis EA, Timmins JG, Armentrout MA, Marchioli CC, Yancey RJJr, Post LE. 1986. DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation. J Virol 59:216-223.
40. Roizman B, Desrosiers RC, Fleckenstein B, Lopez C, Minson AC, Studdert MJ. 1992. The family Herpesviridae: An update. Arch Virol 123:425-559.
41. Scinicariello F, Eberle R, Hilliard JK. 1993. Rapid detection of B virus (Herpesvirus simiae) DNA by polymerase chain reaction. J Infect Dis 168:747-750.
42. Scinicariello F, English WJ, Hilliard J. 1993a. Identification by PCR of meningitis caused by herpes B virus. Lancet 341:1660-1661.
43. Simian Virus Committee. 1985. The management of simians in relation to infectious hazards to staff. Medical Research Council, London.
44. Slomka MJ, Brown DWG, Clewley JP, Bennett AM, Harrington L, Kelly DC. 1993. Polymerase chain reaction for detection of Herpesvirus simiae (B virus) in clinical specimens. Arch Virol 131:89-99.
45. Slomka MJ, Brown DWG. 1995. PCR for the detection of herpesvirus simiae (B virus) in clinical specimens. In: Becker Y, Darai G, editors. PCR: Protocols for diagnosis of human and animal virus diseases. Berlin: Springer Verlag. p 253-264.
46. Slomka MJ, Ashley RL, Cowan FM, Cross A, Brown DWG. 1995a. Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: Comparison with Western blot assay. J Virol Methods 55:27-35.
47. Slomka MJ, Harrington L, Arnold C, Norcott JPN, Brown DWG. 1995b. Complete nucleotide sequence of the herpesvirus simiae glycoprotein G gene and its expression as an immunogenic fusion protein in bacteria. J Gen Virol 76:2161-2168.
48. Tartaglia J, Cox WI, Taylor J, Perkus M, Riviere M, Meignier B, Paoletti E. 1992. Live vectors as vaccines: Highly Attenuated Pox-virus Vectors. AIDS Res Hum Retroviruses 8:1445-1447.
49. Tikoo SK, Fitzpatrick DR, Babiuk LA, Zamb TJ. 1990. Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol 64:5132-5142.
50. Van Drunen Littel-Van Den Hurk S, Babiuk LA. 1986. Synthesis and processing of bovine herpesvirus 1 glycoproteins. J Virol 59:401-410.
51. Vizozo AD. 1975. Latency of herpes simiae (B virus) in rabbits. British J Exp Pathol 56:489-494.
52. Wall LVM, Zwartouw HT, Kelly DC. 1989. Discrimination between twenty isolates of Herpesvirus simiae (B virus) by restriction enzyme analysis of the viral genome. Virus Res 12:283-296.
53. Wachsman M, Aurelian L, Smith CC, Lipinskas BR, Perkus ME, Paoletti E. 1987. Protection of guinea pigs from primary and recurrent herpes simplex virus (HSV) type 2 cutaneous disease with vaccinia virus recombinants expressing HSV glycoprotein D. J Infect Dis 155:1188-1197.
54. Ward JA, Hilliard JK. 1994. B virus specific pathogen-free (SPF) breeding colonies of macaques: Issues, surveillance, and results in 1992. Lab Anim Scie 44:222-228.
55. Weigler BJ. 1992. Biology of B virus in macaque and human hosts: A review. Clin Infect Dis 14:555-567.
56. Weigler BJ, Scinicariello F, Hilliard JK. 1995. Risk of venereal B virus (Cercopithecine herpesvirus 1) transmission in rhesus monkeys using molecular epidemiology. J Infect Dis 171:1139-1143.
57. Zwartouw HT, Boulter EA. 1984. Excretion of B virus in monkeys and evidence of genital infection. Lab Anim 18:65-67.